Avalo Therapeutics (NASDAQ:AVTX) Coverage Initiated at BTIG Research
BTIG Research assumed coverage on shares of Avalo Therapeutics (NASDAQ:AVTX – Free Report) in a research note published on Thursday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $40.00 price target on the stock. Separately, HC Wainwright assumed coverage on shares of Avalo Therapeutics in a report on Thursday, October 24th. […]
22 Dec 09:54 · The Markets Daily